RAC1 and breast carcinoma: This is in agreement with previous reports showing a link between ABL kinases and TRIO or RAC1 [15, 16] and with a recent study demonstrating a negative regulatory role of the TRIO-RAC1 axis on invadopodia activity of breast carcinoma cells [14].